RBC Capital Reiterates Outperform on Boston Scientific, Maintains $70 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Boston Scientific (NYSE:BSX) and maintained a $70 price target on the stock.
February 05, 2024 | 3:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital maintains an Outperform rating and a $70 price target on Boston Scientific, indicating a positive outlook on the stock.
The reiteration of an Outperform rating and a maintained price target of $70 by a reputable analyst like Shagun Singh from RBC Capital suggests a strong confidence in Boston Scientific's future performance. This endorsement is likely to instill positive sentiment among investors, potentially driving the stock's price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100